Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Kusi, Kwadwo A ^a,b   Faber, Bart W ^a   Van Der Eijk, Marjolein ^a   Thomas, Alan W ^a   Kocken, Clemens Hm ^a   Remarque, Edmond J ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; MALARIA VACCINE; PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1; PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1 ANTIBODY; UNCLASSIFIED DRUG; APICAL MEMBRANE ANTIGEN I, PLASMODIUM; EPITOPE; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ALLELE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIPROTOZOAL ACTIVITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; RABBIT; ANIMAL; BLOOD; CROSS PROTECTION; IMMUNOLOGY; METHODOLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CROSS PROTECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; IMMUNIZATION; MALARIA VACCINES; MEMBRANE PROTEINS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RABBITS;

EID: 79851516179     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-40     Document Type: Article

References (38)

1. WHO, World malaria Report Geneva: WHO Press 2008
2. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. JK Baird, Parasitol Today 1995 11 105 111 10.1016/0169-4758(95) 80167-7 15275362
3. Acquired immunity to malaria. DL Doolan C Dobano JK Baird, Clin Microbiol Rev 2009 22 13 36 10.1128/CMR.00025-08 19136431
4. Does malaria suffer from lack of memory? SS Struik EM Riley, Immunol Rev 2004 201 268 290 10.1111/j.0105-2896.2004.00181.x 15361247 (Pubitemid 39318458)
5. Immunity to asexual blood stage malaria and vaccine approaches. J Wipasa S Elliott H Xu MF Good, Immunol Cell Biol 2002 80 401 414 10.1046/j.1440-1711. 2002.01107.x 12225376
6. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. AA Escalante AA Lal FJ Ayala, Genetics 1998 149 189 202 9584096
7. Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. S Franks L Baton K Tetteh E Tongren D Dewin BD Akanmori KA Koram L Ranford-Cartwright EM Riley, Infect Immun 2003 71 3485 3495 10.1128/IAI.71.6.3485-3495.2003 12761133 (Pubitemid 36637577)
8. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. EH Hoffmann LA Da Silveira R Tonhosolo FJ Pereira WL Ribeiro AP Tonon F Kawamoto MU Ferreira, Ann Trop Med Parasitol 2001 95 117 132 10.1080/00034980120045833 11299119 (Pubitemid 32304210)
9. Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. SD Polley DJ Conway, Genetics 2001 158 1505 1512 11514442 (Pubitemid 32783136)
10. Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum. AW Thomas AP Waters D Carr, Mol Biochem Parasitol 1990 42 285 287 10.1016/0166-6851(90)90172-I 2270110 (Pubitemid 20283955)
11. Mixed allele malaria vaccines: host protection and within-host selection. VC Barclay BH Chan RF Anders AF Read, Vaccine 2008 26 6099 6107 10.1016/j.vaccine.2008.09.004 18804509
12. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. PE Crewther ML Matthew RH Flegg RF Anders, Infect Immun 1996 64 3310 3317 8757869 (Pubitemid 26256181)
13. Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. CF Ockenhouse E Angov KE Kester C Diggs L Soisson JF Cummings AV Stewart DR Palmer B Mahajan U Krzych N Tornieporth M Delchambre M Vanhandenhove O Ofori-Anyinam J Cohen JA Lyon DG Heppner, Vaccine 2006 24 3009 3017 10.1016/j.vaccine.2005.11.028 16356603
14. Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya. FH Osier GD Weedall F Verra L Murungi KK Tetteh P Bull BW Faber E Remarque A Thomas K Marsh DJ Conway, Infect Immun 2010 78 4625 4633 10.1128/IAI.00576-10 20732997
15. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. MD Spring JF Cummings CF Ockenhouse S Dutta R Reidler E Angov E Bergmann-Leitner VA Stewart S Bittner L Juompan MG Kortepeter U Nielsen E Krzych LA Tierney M Ware CC Dowler RW Hermsen R Sauerwein SJ de Vlas O Ofori-Anyinam DE Lanar JL Williams KE Kester K Tucker M Shi E Malkin C Long CL Diggs L Soisson MC Dubois WR Ballou J Cohen DG Heppner, PLoS ONE 2009 4 5254 10.1371/journal.pone.0005254 19390585
16. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. SL Takala D Coulibaly MA Thera A Dicko DL Smith AB Guindo AK Kone K Traore A Ouattara AA Djimde PS Sehdev KE Lyke DA Diallo OK Doumbo CV Plowe, PLoS Med 2007 4 93 10.1371/journal.pmed.0040093 17355170
17. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria. EM Malkin DJ Diemert JH McArthur JR Perreault AP Miles BK Giersing GE Mullen A Orcutt O Muratova M Awkal H Zhou J Wang A Stowers CA Long S Mahanty LH Miller A Saul AP Durbin, Infect Immun 2005 73 3677 3685 10.1128/IAI.73.6.3677-3685.2005 15908397 (Pubitemid 40745912)
18. Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria. GE Mullen RD Ellis K Miura E Malkin C Nolan M Hay MP Fay A Saul D Zhu K Rausch S Moretz H Zhou CA Long LH Miller J Treanor, PLoS ONE 2008 3 2940 10.1371/journal.pone.0002940 18698359
19. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses. M Sedegah WO Rogers M Belmonte A Belmonte G Banania NB Patterson D Rusalov M Ferrari TL Richie DL Doolan, Vaccine 2010 28 3055 3065 10.1016/j.vaccine.2009.10.044 19879998
20. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity. KA Kusi BW Faber AW Thomas EJ Remarque, PLoS ONE 2009 4 8110 10.1371/journal.pone.0008110 19956619
21. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. FM Davenport AV Hennessy T Francis Jr, J Exp Med 1953 98 641 656 10.1084/jem.98.6.641 13109114
22. Disquisitions on original antigenic sin. SF de St Groth RG Webster, The J Exp Med 1966 124 331 345 10.1084/jem.124.3.331
23. Molecular analysis of original antigenic sin. I. Clonal selection, somatic mutation, and isotype switching during a memory B cell response. S Fish E Zenowich M Fleming T Manser, J Exp Med 1989 170 1191 1209 10.1084/jem.170.4. 1191 2477487 (Pubitemid 19250688)
24. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. EJ Remarque BW Faber CH Kocken AW Thomas, Infect Immun 2008 76 2660 2670 10.1128/IAI.00170-08 18378635
25. Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris. BW Faber EJ Remarque CH Kocken P Cheront D Cingolani F Xhonneux M Jurado M Haumont S Jepsen O Leroy AW Thomas, Vaccine 2008 26 6143 6150 10.1016/j.vaccine.2008.08.055 18804135
26. Gamma-globulin and acquired immunity to human malaria. S Cohen IA McGregor S Carrington, Nature 1961 192 733 737 10.1038/192733a0 13880318
27. The passive transfer of human malarial immunity. IA McGregor, Am J Trop Med Hyg 1964 13 237 239 14104823
28. High antibody titre against apical membrane antigen-1 is required to protect against malaria in the Aotus model. S Dutta JS Sullivan KK Grady JD Haynes J Komisar AH Batchelor L Soisson CL Diggs DG Heppner DE Lanar WE Collins JW Barnwell, PLoS ONE 2009 4 8138 10.1371/journal.pone.0008138 19997632
29. 'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion. MF Good Y Zevering J Currier J Bilsborough, Parasite Immunol 1993 15 187 193 10.1111/j.1365-3024.1993.tb00599.x 7685075 (Pubitemid 23132178)
30. Human antibodies to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface protein 1 (MSP-1) exhibit a highly skewed, peptide-specific light chain distribution. H Jouin O Garraud S Longacre F Baleux O Mercereau-Puijalon G Milon, Immunol Cell Biol 2005 83 392 395 10.1111/j.1440-1711.2005.01343.x 16033534 (Pubitemid 41044616)
31. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. RR Taylor A Egan D McGuinness A Jepson R Adair C Drakely E Riley, Int Immunol 1996 8 905 915 10.1093/intimm/8.6.905 8671680 (Pubitemid 26185928)
32. Overcoming original (antigenic) sin. DE Anderson MP Carlos L Nguyen JV Torres, Clin Immunol 2001 101 152 157 10.1006/clim.2001.5114 11683574
33. Original antigenic sin responses to influenza viruses. JH Kim I Skountzou R Compans J Jacob, J Immunol 2009 183 3294 3301 10.4049/jimmunol.0900398 19648276
34. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. J Mongkolsapaya W Dejnirattisai XN Xu S Vasanawathana N Tangthawornchaikul A Chairunsri S Sawasdivorn T Duangchinda T Dong S Rowland-Jones PT Yenchitsomanus A McMichael P Malasit G Screaton, Nat Med 2003 9 921 927 10.1038/nm887 12808447 (Pubitemid 36889936)
35. Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of response. KA Kusi BW Faber V Riasat AW Thomas CH Kocken EJ Remarque, PLoS ONE 2010 5 15391 10.1371/journal.pone.0015391 21082025
36. Specificity of the protective antibody response to apical membrane antigen 1. AN Hodder PE Crewther RF Anders, Infect Immun 2001 69 3286 3294 10.1128/IAI.69.5.3286-3294.2001 11292751 (Pubitemid 32332227)
37. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. MC Kennedy J Wang Y Zhang AP Miles F Chitsaz A Saul CA Long LH Miller AW Stowers, Infect Immun 2002 70 6948 6960 10.1128/IAI.70.12. 6948-6960.2002 12438374 (Pubitemid 35387930)
38. Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial. MA Thera OK Doumbo D Coulibaly DA Diallo I Sagara A Dicko DJ Diemert DG Heppner VA Stewart E Angov L Soisson A Leach K Tucker KE Lyke CV Plowe, PLoS Clin Trials 2006 1 34 10.1371/journal. pctr.0010034 17124530